Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Plasma rich in growth factors

Other · developed by Biotechnology Institute IMASD

Phase 2 Most advanced trial (none active)
1 Registered trials

What is Plasma rich in growth factors?

Plasma rich in growth factors (PRGF) is a preparation administered intrauterine.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Other
Therapy area
Renal & urology
Developer
Biotechnology Institute IMASD
In trials of
RFL
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03387501 Phase 2 Infertility Completed RFL

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

InfertilityInfertility, Female

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.